Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin Pamoate 3-month SC in Prostate Cancer
NCT01715129Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jan 2013
- Primary completion
- Oct 2013
- Modality
- Peptides, Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of triptorelin pamoate in prostate cancer (PCa), sponsored by Ipsen. Started Jan 2013; status: completed.
02
Drugs
triptorelin pamoate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01715129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715129.